The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment

The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment

Abstract Introduction An Alzheimer's disease (AD) biomarker adjusted for age‐related brain changes should improve specificity for AD‐related pathological burden. Methods We calculated a brain‐age‐adjusted “personalized AD cortical thickness index” (pADi) in mild cognitive impairment patients fr...

Full description

Bibliographic Details
Main Authors: Annie M. Racine, Michael Brickhouse, David A. Wolk, Bradford C. Dickerson, Alzheimer's Disease Neuroimaging Initiative
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
AD index
AD signature
Alzheimer's disease
Cortical thickness
Mild cognitive impairment
Online Access:https://doi.org/10.1016/j.dadm.2018.02.007

Internet

https://doi.org/10.1016/j.dadm.2018.02.007

Similar Items